Jonathan Ledermann

Default user avatar

University College London
CR-UK & UCL Clinical Trials Centre
90 Tottenham Court Road
London
W1T 4TJ
United Kingdom

Email: j.ledermann@ctc.ucl.ac.uk
Tel: 020 7679 9898
Web: Lab website

About Jonathan Ledermann

Professor Jonathan Ledermann is leading an international clinical trial of a new treatment for women with ovarian cancer. This disease often becomes resistant to chemotherapy, making it difficult to treat. The new drug could help to block blood vessel growth in the tumour, starving the cancer cells.

More about Jonathan Ledermann

Jonathan Ledermann other research projects

CRUK/07/025: ICON6: An international randomised trial of molecular targeted therapy with AZD2171 with Pt-based chemotherapy for patients with ovarian cancer relapsing more than 6 months following completion of first line Pt-based
Phase III Clinical Trial Grants
Funding period: 01 July 2007 to 30 June 2014

Phase III Clinical Trial Grants
Funding period: 01 October 2008 to 30 September 2013

Recent publications


Inhibition of Carboplatin-Induced DNA Interstrand Cross-link Repair by Gemcitabine in Patients Receiving these Drugs for Platinum-Resistant Ovarian Cancer

Clin Cancer Res.2010;16 :4899-4905

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer

J Natl Cancer Inst.2009;101 :341-349

More publications…